Question explored with the scientific record
What are some natural treatments for Sjogren’s
The honest answer: the natural options for Sjögren's have thin, indirect evidence, and most of what was retrieved is about dry mouth and dry eye in general, not Sjögren's specifically.
The retrieval is mostly about xerostomia (dry mouth) and dry eye from any cause, not Sjögren's. Sjögren's is a systemic autoimmune disease that inflames the exocrine glands, mainly the salivary and tear glands, causing dryness of mouth, eyes, nose, throat, and vagina [2]. So the closest evidence is symptom relief, not disease modification.
What the records actually show. For dry mouth, sugar-free gums and lozenges, saliva substitutes, oral moisturizers, and a bedside humidifier at night improve lubrication and comfort [5][6]. A randomized crossover trial of oral saliva products in 209 people (67 with Sjögren's) found all three cut mouth dryness by 10 to 19 percent on a 100-point scale, with the best product beating the weakest by about 6 points, and none hitting the 50 percent reduction target [11]. Acupuncture was linked to a prolonged rise in saliva flow [7], and electrical stimulation of the parotid gland increased saliva production [8], but these are small, uncontrolled reports. For dry eyes, artificial tears are the most studied category, and a review of 49 trials found the endpoints so inconsistent that firm conclusions are impossible [1]. Lubricant ingredients differ in friction in lab testing [3], which is a lab measure, not a symptom outcome.
Omega-3 is the supplement people ask about most. The retrieved omega-3 trials are in other conditions entirely: periodontitis, heart disease, COPD, dysmenorrhea [4][5][9][8]. None tested Sjögren's. One trial in healthy older adults did lower inflammatory markers [10], but that is a lab value, not a Sjögren's outcome.
| Option | Best evidence here | What it shows |
|---|---|---|
| Saliva substitutes | RCT, 209 people [11] | 10-19% less dryness; target missed |
| Gum/lozenges, humidifier | Review [5][6] | Symptom relief only |
| Acupuncture | Small reports [7] | Possible saliva increase |
| Omega-3 | No Sjögren's trial [4][5] | Unproven here |
My call: for symptom relief, saliva substitutes, sugar-free gum, humidifiers, and artificial tears are reasonable and low-risk, but none of this evidence shows they change the disease. Omega-3 for Sjögren's is unproven in these records. Confidence: low, because the retrieval contains no Sjögren's-specific natural-treatment trial.
Sources used 11
-
Dry Eye Disease Treatment: A Systematic Review of Published Trials and a Critical Appraisal of Therapeutic Strategies
This study systematically reviews published randomized trials of dry eye disease treatments, analyzes trial endpoints and public trial registries, and concludes that while many therapies exist, heterogeneity and lack of standardized outcomes hinder meta-analyses and definitive c…
DOI: 10.1016/j.jtos.2013.02.002 -
Corneal ectasia with Stevens–Johnson syndrome
This case report describes a 45-year-old woman with bilateral corneal ectasia in the setting of Stevens–Johnson syndrome, detailing initial improvement with corneo-scleral lenses followed by progression of ocular surface disease, and subsequent refitting to larger-diameter scler…
DOI: 10.1080/08164622.2021.1878835 -
Differential tissue‐on‐tissue lubrication by ophthalmic formulations
This study investigates the lubrication properties of various ophthalmic formulations in tissue-on-tissue friction testing, revealing that a formulation containing polyethylene glycol and hydroxypropyl guar significantly reduces friction compared to saline and other formulations.
DOI: 10.1002/jbm.b.30707 -
Dietary supplementation with low‐dose omega‐3 fatty acids reduces salivary tumor necrosis factor‐α levels in patients with chronic periodontitis: a randomized controlled clinical study
This study investigates the effects of low-dose omega-3 fatty acid supplementation on salivary tumor necrosis factor (TNF)-a and superoxide dismutase (SOD) levels in patients with chronic periodontitis undergoing scaling and root planing, finding significant reductions in TNF-a …
DOI: 10.1111/jre.12434 -
Omega‐3 fatty acids for the prevention of atherosclerotic cardiovascular disease
This narrative review synthesizes randomized trial evidence on omega-3 fatty acids for prevention of atherosclerotic cardiovascular disease, highlighting limited benefit from low-dose formulations but a notable reduction in major adverse cardiovascular events with high-dose icos…
DOI: 10.1002/phar.2615 -
Streamlined mail-based methods for large randomised trials: lessons learnt from the ASCEND study
This is a review describing how the ASCEND diabetes trial implemented streamlined, mail-based randomised methods (including a two-by-two factorial design assessing low-dose aspirin and omega-3 fatty acids) to evaluate vascular outcomes in 15,480 diabetes patients without overt c…
DOI: 10.1007/s00125-019-05049-8 -
Treatment of Aspirin-Resistant Patients With Omega-3 Fatty Acids Versus Aspirin Dose Escalation
Omega-3 fatty acids added to low-dose aspirin or escalation to 325 mg aspirin for 30 days improves aspirin responsiveness in aspirin-resistant CAD patients, reducing platelet reactivity and thromboxane B2 with similar efficacy.
DOI: 10.1016/j.jacc.2009.08.039 -
Aerobic Exercise and Omega 3 Supplementation to Reduce Primary Dysmenorrhea (Literature Review)
This literature review concludes that regular aerobic exercise and omega-3 supplementation can reduce primary dysmenorrhea, likely via increased progesterone and inhibited prostaglandin production.
DOI: 10.37506/ijfmt.v15i3.15503 -
Effects of Omega-3 Polyunsaturated Fatty Acids to The Serum Level of Interleukin-8, Percentage of Forced Expiratory Volume in 1 Second (%FEV1), and COPD Assesment Test Scores in Stable COPD Patients
In stable COPD outpatients, 28-day omega-3 PUFA 600 mg/day reduced serum IL-8 and CAT scores versus standard therapy but did not significantly improve %VEP1.
DOI: 10.36497/jri.v37i4.80 -
Omega-3 supplementation lowers inflammation in healthy middle-aged and older adults: A randomized controlled trial
This randomized controlled trial demonstrated that omega-3 supplementation significantly reduces inflammation markers in healthy middle-aged and older adults, while having minimal impact on depressive symptoms.
DOI: 10.1016/j.bbi.2012.05.011 -
Efficacy and safety of a new oral saliva equivalent in the management of xerostomia: a national, multicenter, randomized study
A national, multicenter, randomized 2-week crossover trial comparing Novasial versus Aequasyal and Biotene in adults with xerostomia found modest improvements in mouth dryness for all treatments, with Novasial slightly outperforming Aequasyal but not significantly different from…
DOI: 10.1016/j.oooo.2014.12.005